MO ACTIVITIES
Board
5 directors, no change since September 2026MED.OPHTA BVBA
Director, permanent representative Jean Assaf
since 18-11-2025
6-year term from 2025
also on the board of 1 other company
listed in the 2025 annual accounts, filed on 01-07-2026
Signifeye NV
Director, permanent representative Kathleen Moons
since 18-11-2025
6-year term from 2025
also on the board of 3 other companies
listed in the 2025 annual accounts, filed on 01-07-2026
EQIRIS NV
Director, permanent representative Bernard Heintz
since 27-11-2025
6-year term from 2025
also on the board of 3 other companies
listed in the 2025 annual accounts, filed on 01-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Au moins deux (2) membres de l’organe d’administration doivent être des ophtalmologues, agissant ou non en tant que représentant permanent…”deed of 11-02-2026
Permanent representatives 3
Mandates through the years
7 names, the dashed line is todayMED.OPHTA
Director
Director
Signifeye
Director
Director
EQIRIS
Director
Director
Merel Venneman
Director
Director
Lode Vlaminck
Director
Director
Movendis BV
Director
Director
Jean Assaf
Director
Director
BoardEarlierRest of the termmandate already running before its first mention
Mandates as a list
- MED.OPHTA
- Director, from 05-07-2021 to date
- Signifeye
- Director, from 18-11-2025 to date
- EQIRIS
- Director, from 27-11-2025 to date
- Merel Venneman
- Director, appointed by deed of 30-09-2026, still in office
- Lode Vlaminck
- Director, appointed by deed of 30-09-2026, still in office
- Movendis BV
- Director, until 30-09-2026
- Jean Assaf
- Director, from 05-07-2021 to 23-12-2025
Control
100%
This company
MO ACTIVITIES
Equity €2.8m
Profit €829,040 in 2025
Further up the chainSignifeye 100%
Capital
- Contribution
- €11,874.72
- Shares
- 750
- Contribution per share
- €15.83
- Equity per share
- €3,770 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 11-02-2026 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 3 directorsAt least 2 directors“Dûment reconnus et autorisés à exercer la médecine en Belgique conformément aux dispositions légales et déontologiques”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Monday of June at 11:30
Capital transactions
Capital over time
- 11-02-2026 Capital stated in the deed · 750 shares
- 13-07-2021 Incorporation · €1,174,295.21